文献速递牙体牙髓病

大麻二酚作为急性牙痛替代镇痛药的随机对照试验

Cannabidiol as an Alternative Analgesic for Acute Dental Pain.
PubMed 文献 · J Dent Res · 2023-11-01

两种CBD剂量均较基线和安慰剂显著降低VAS疼痛,CBD20起效更快,且未出现其他显著精神活性或情绪改变。

要点

  • CBD10与CBD20单次口服均较安慰剂显著降低急性牙痛VAS评分。
  • CBD20在给药后15分钟即出现显著疼痛缓解,快于CBD10的30分钟。
  • 需注意镇静、腹泻和腹痛与CBD组显著相关。

核心结论

  • 口服CBD对急诊急性牙痛具有显著镇痛效果且总体安全。

研究设计与样本

  • 单次口服相应溶液后监测3小时,主要结局为组内及组间VAS疼痛较基线的数值差异。

主要发现

  • 两个CBD组VAS疼痛均较基线和安慰剂组显著降低,180分钟时最大中位VAS疼痛降幅达基线疼痛的73%(P < 0.05)。
  • CBD20出现显著疼痛缓解的起效时间快于CBD10(给药后15分钟 vs 30分钟),两组均在180分钟达到最大疼痛缓解。
  • 需治疗人数CBD10为3.1,CBD20为2.4。
  • 两个CBD组组内咬合力显著增加(P < 0.05),安慰剂组无显著变化(P > 0.05);CBD20在90和180分钟时平均咬合力变化百分比与安慰剂组有显著差异(P < 0.05)。
  • 与安慰剂相比,镇静、腹泻和腹痛与CBD组显著相关(P < 0.05),未观察到其他显著精神活性或情绪改变效应。

临床怎么用

  • 对于急诊中重度牙痛患者,可考虑单次口服CBD 10–20 mg/kg作为非阿片类镇痛选择。
  • 使用CBD时需监测镇静、腹泻和腹痛等不良反应。

局限性

  • 未报告长期镇痛效果及重复给药的安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Odontogenic pain can be debilitating, and nonopioid analgesic options are limited. This randomized placebo-controlled clinical trial aimed to assess the effectiveness and safety of cannabidiol (CBD) as an analgesic for patients with emergency acute dental pain. Sixty-one patients with moderate to severe toothache were randomized into 3 groups: CBD10 (CBD 10 mg/kg), CBD20 (CBD 20 mg/kg), and placebo. We administered a single dose of respective oral solution and monitored the subjects for 3 h. The primary outcome measure was the numerical pain differences using a visual analog scale (VAS) from baseline within and among the groups. Secondary outcome measures included ordinal pain intensity differences, the onset of significant pain relief, maximum pain relief, changes in bite force within and among the groups, psychoactive effects, mood changes, and other adverse events. Both CBD groups resulted in significant VAS pain reduction compared to their baseline and the placebo group, with a maximum median VAS pain reduction of 73% from baseline pain at the 180-min time point (P < 0.05). CBD20 experienced a faster onset of significant pain relief than CBD10 (15 versus 30 min after drug administration), and both groups reached maximum pain relief at 180-min. Number needed to treat was 3.1 for CBD10 and 2.4 for CBD20. Intragroup comparisons showed a significant increase in bite forces in both CBD groups (P < 0.05) but not in the placebo group (P > 0.05). CBD20 resulted in a significant difference in mean percent bite force change in the 90- and 180-min time points compared to the placebo group (P < 0.05). Compared to placebo, sedation, diarrhea, and abdominal pain were significantly associated with the CBD groups (P < 0.05). There were no other significant psychoactive or mood change effects. This randomized trial provides the first clinical evidence that oral CBD can be an effective and safe analgesic for dental pain.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Chrepa V, Villasenor S, Mauney A, et al. Cannabidiol as an Alternative Analgesic for Acute Dental Pain. J Dent Res. 2023. PMID: 37910667. doi:10.1177/00220345231200814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。